List of Medically Important Antimicrobial Drugs Affected by GFI #213
Type of Application | Application Number | Sponsor | Ingredient(s) | Action(s) |
---|---|---|---|---|
Pioneer | 006-084 | Huvepharma EOOD | Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 006-391 | Huvepharma EOOD | Sulfaquinoxaline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 006-677 | Huvepharma EOOD | Sulfaquinoxaline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 006-707 | Zoetis Inc. | Sulfaquinoxaline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 006-891 | Huvepharma EOOD | Sulfaquinoxaline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 007-076 | Cross Vetpharm Group Ltd. | Sulfaquinoxaline | Application Voluntarily Withdrawn (81 FR 36790, June 8, 2016; 81 FR 36787, June 8, 2016) |
Pioneer | 007-087 | Huvepharma EOOD | Sulfaquinoxaline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 008-244 | Cross Vetpharm Group Ltd. | Sulfaquinoxaline | Application Voluntarily Withdrawn (81 FR 36790, June 8, 2016; 81 FR 36787, June 8, 2016) |
Pioneer | 008-622 | Zoetis Inc. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 008-804 | Phibro Animal Health Corp. | Oxytetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 010-092 | Cross Vetpharm Group Ltd. | Erythromycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 010-918 | Elanco US, Inc. | Hygromycin B | Supplemental application approved to change to veterinary oversight* |
Pioneer | 011-315 | Zoetis Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 012-491 | Elanco US, Inc. | Tylosin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 013-076 | Elanco US, Inc. | Tylosin | Veterinary Oversight (79 FR 37617, July 2, 2014) |
Pioneer | 013-162 | Elanco US, Inc. | Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Pioneer | 013-214 | Virbac AH, Inc. | Hygromycin B | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 015-160 | Zoetis Inc. | Sulfachloropyrazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 015-166 | Elanco US, Inc. | Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Pioneer | 031-205 | Zoetis Inc. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 031-553 | Zoetis Inc. | Sulfachloropyrazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 032-946 | Zoetis Inc. | Carbomycin, Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 033-373 | Huvepharma EOOD | Sulfachlorpyridazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 033-950 | Zoetis Inc. | Sulfamerazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 034-085 | Zoetis Inc. | Lincomycin | Sponsor has requested withdrawal of approval* |
Pioneer | 035-157 | Cross Vetpharm Group Ltd. | Erythromycin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 035-287 | Phibro Animal Health Corp. | Oleandomycin | Sponsor has requested withdrawal of approval* |
Pioneer | 035-688 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight*; Reformulated without penicillin; production indications withdrawn. (79 FR 37621, July 2, 2014; 79 FR 37622, July 2, 2014) |
Pioneer | 035-805 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 038-200 | Phibro Animal Health Corp. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 038-241 | Cross Vetpharm Group Ltd. | Arsanilic Acid, Erythromycin, Zoalene | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Pioneer | 038-242 | Cross Vetpharm Group Ltd. | Amprolium, Arsanilic Acid, Erythromycin, Ethopabate | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Pioneer | 038-439 | Phibro Animal Health Corp. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 038-624 | Cross Vetpharm Group Ltd. | Arsanilic Acid, Erythromycin | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Pioneer | 038-661 | Cross Vetpharm Group Ltd. | Spectinomycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 039-077 | Zoetis Inc. | Chlortetracycline, Penicillin, Sulfathiazole | Application Voluntarily Withdrawn (79 FR 15540, March 20, 2014; 79 FR 15441, March 20, 2014) |
Pioneer | 040-209 | Zoetis Inc. | Ormetoprim, Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-275 | Elanco US, Inc. | Tylosin, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-647 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-648 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-649 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-650 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-651 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-652 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-653 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-654 | Zoetis Inc. | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 041-955 | Cross Vetpharm Group Ltd. | Erythromycin | Application Voluntarily Withdrawn (81 FR 36790, June 8, 2016; 81 FR 36787, June 8, 2016) |
Pioneer | 042-660 | Virbac AH, Inc. | Sulfamethazine, Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 043-387 | Virbac AH, Inc. | Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 046-109 | Zoetis Inc. | Lincomycin, Spectinomycin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 046-285 | Zoetis Inc. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 046-415 | Zoetis Inc. | Tylosin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 046-666 | Zoetis Inc. | Penicillin | Application Voluntarily Withdrawn (80 FR 61293, October 13, 2015; 80 FR 61298, October 13, 2015) |
Pioneer | 046-668 | Phibro Animal Health Corp. | Penicillin | Sponsor has requested withdrawal of approval* |
Pioneer | 046-699 | Zoetis Inc. | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 048-480 | Pharmgate LLC | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 048-761 | Zoetis Inc. | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 049-287 | Zoetis Inc. | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 049-729 | Cross Vetpharm Group Ltd. | Sulfamethazine | Application Voluntarily Withdrawn (81 FR 36790, June 8, 2016; 81 FR 36787, June 8, 2016) |
Pioneer | 055-012 | Huvepharma EOOD | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 055-020 | Zoetis Inc. | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 055-060 | Zoetis Inc. | Penicillin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-071 | Huvepharma EOOD | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-123 | Zoetis Inc. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-140 | Huvepharma EOOD | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-178 | Phibro Animal Health Corp. | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-252 | Huvepharma EOOD | Streptomycin | Veterinary Oversight (80 FR 61293, October 13, 2015) |
Pioneer | 065-256 | Pharmgate LLC | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-269 | Huvepharma AD | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-410 | Zoetis Inc. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-440 | Huvepharma EOOD | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-441 | Zoetis Inc. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-480 | Pharmgate LLC | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-486 | Strategic Veterinary Pharmaceuticals, Inc. | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 065-496 | Phibro Animal Health Corp. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 091-191 | Intervet, Inc. | Gentamicin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 091-467 | Phibro Animal Health Corp. | Virginiamycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 091-513 | Phibro Animal Health Corp. | Virginiamycin | Sponsor has requested withdrawal of approval* |
Pioneer | 091-582 | ADM Alliance Nutrition, Inc. | Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 091-668 | Zoetis Inc. | Chlortetracycline, Penicillin, Sulfamethazine | Sponsor has requested withdrawal of approval* |
Pioneer | 091-749 | Zoetis Inc. | Sulfamethazine, Tylosin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 092-286 | Phibro Animal Health Corp. | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 092-287 | Phibro Animal Health Corp. | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 094-975 | Phibro Animal Health Corp. | Neomycin, Oxytetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 095-143 | Phibro Animal Health Corp. | Oxytetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 097-505 | Zoetis Inc. | Lincomycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 098-431 | Phibro Animal Health Corp. | Tylosin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 099-468 | Ridley USA Inc. | Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 099-767 | Virbac AH, Inc. | Sulfamethazine, Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 100-094 | Huvepharma EOOD | Sulfamerazine, Sulfamethazine, Sulfaquinoxaline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 100-128 | Cross Vetpharm Group Ltd. | Tylosin | Application Voluntarily Withdrawn (81 FR 36790, June 8, 2016; 81 FR 36787, June 8, 2016) |
Pioneer | 100-901 | Zoetis Inc. | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 106-964 | Elanco US, Inc. | Apramycin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 108-484 | ADM Alliance Nutrition, Inc. | Sulfamethazine, Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 110-045 | ADM Alliance Nutrition, Inc. | Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 110-439 | ADM Alliance Nutrition, Inc. | Hygromycin B | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 111-636 | Zoetis Inc. | Lincomycin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 122-272 | Huvepharma EOOD | Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 125-933 | Pharmaq AS | Ormetoprim, Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Pioneer | 126-050 | Elanco US, Inc. | Apramycin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 127-507 | Elanco US, Inc. | Sulfamethazine, Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Pioneer | 128-411 | ADM Alliance Nutrition, Inc. | Sulfamethazine, Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 130-435 | Huvepharma EOOD | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 131-958 | Ridley USA Inc. | Sulfamethazine, Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 132-574 | Virbac AH, Inc. | Lincomycin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 133-334 | Zoetis Inc. | Virginiamycin | Sponsor has requested withdrawal of approval* |
Pioneer | 133-836 | Intervet, Inc. | Gentamicin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 138-187 | Micro Beef Technologies LTD | Tylosin | Application Voluntarily Withdrawn (79 FR 19814, April 10, 2014; 79 FR 19816, April 10, 2014) |
Pioneer | 138-934 | Pharmgate LLC | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight*; Reformulated without penicillin, production indications withdrawn |
Pioneer | 138-935 | Pharmgate LLC | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 138-938 | Pharmgate LLC | Oxytetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 138-939 | Pharmgate LLC | Neomycin, Oxytetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Pioneer | 140-443 | Zoetis Inc. | Hygromycin B | Sponsor has requested withdrawal of approval* |
Pioneer | 140-578 | Zoetis Inc. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Pioneer | 140-680 | Pharmgate LLC | Tylosin | Application Voluntarily Withdrawn (80 FR 76384, December 9, 2015; 80 FR 76387, December 9, 2015) |
Pioneer | 140-681 | Pharmgate LLC | Sulfamethazine, Tylosin | Application Voluntarily Withdrawn (80 FR 76384, December 9, 2015; 80 FR 76387, December 9, 2015) |
Pioneer | 140-976 | Zoetis Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Pioneer | 140-998 | Phibro Animal Health Corp. | Virginiamycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Generic | 200-026 | Pharmgate LLC | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-030 | Agri Laboratories, Ltd. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-031 | Agri Laboratories, Ltd. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-046 | Zoetis Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-049 | Agri Laboratories, Ltd. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-050 | Cross Vetpharm Group Ltd. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-066 | Agri Laboratories, Ltd. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-103 | Cross Vetpharm Group Ltd. | Penicillin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-106 | Huvepharma EOOD | Penicillin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-113 | Zoetis Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-118 | Huvepharma EOOD | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-122 | Zoetis Inc. | Penicillin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-130 | Huvepharma EOOD | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-136 | Quo Vademus, LLC | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-140 | Zoetis Inc. | Chlortetracycline, Penicillin, Sulfathiazole | Application Voluntarily Withdrawn (79 FR 15540, March 20, 2014; 79 FR 15441, March 20, 2014) |
Generic | 200-144 | Cross Vetpharm Group Ltd. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-146 | Cross Vetpharm Group Ltd. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-153 | Huvepharma EOOD | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-165 | Strategic Veterinary Pharmaceuticals, Inc. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-167 | Zoetis Inc. | Chlortetracycline, Penicillin, Sulfathiazole | Application Voluntarily Withdrawn (79 FR 15540, March 20, 2014; 79 FR 15441, March 20, 2014) |
Generic | 200-185 | Agri Laboratories, Ltd. | Gentamicin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-189 | Huvepharma EOOD | Lincomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-190 | Med-Pharmex, Inc. | Gentamicin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-192 | Huvepharma EOOD | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-197 | Huvepharma EOOD | Streptomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-233 | Zoetis Inc. | Lincomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-234 | Med-Pharmex, Inc. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-235 | Med-Pharmex, Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-236 | Quo Vademus, LLC | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-238 | Med-Pharmex, Inc. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-241 | Med-Pharmex, Inc. | Lincomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-247 | Cross Vetpharm Group Ltd. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-251 | Med-Pharmex, Inc. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-258 | Phibro Animal Health Corp. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-289 | Med-Pharmex, Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-295 | Pharmgate LLC | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-303 | Quo Vademus, LLC | Lincomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-305 | Vetoquinol N.-A., Inc. | Oxytetracycline | Application Voluntarily Withdrawn (79 FR 74021, December 15, 2014; 79 FR 74018, December 15, 2014) |
Generic | 200-307 | Vetoquinol N.-A., Inc. | Penicillin | Application Voluntarily Withdrawn (81 FR 36790, June 8, 2016; 81 FR 36787, June 8, 2016) |
Generic | 200-314 | Pharmgate LLC | Chlortetracycline, Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-345 | Phibro Animal Health Corp. | Lincomycin, Spectinomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-347 | Quo Vademus, LLC | Penicillin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-372 | G.C. Hanford Manufacturing Co. | Penicillin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-374 | Cross Vetpharm Group Ltd. | Tetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-376 | Cross Vetpharm Group Ltd. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-377 | Cross Vetpharm Group Ltd. | Lincomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-378 | Sparhawk Laboratories, Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-379 | Sparhawk Laboratories, Inc. | Neomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-380 | Cross Vetpharm Group Ltd. | Lincomycin, Spectinomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-407 | Agri Laboratories, Ltd. | Lincomycin, Spectinomycin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-434 | Cross Vetpharm Group Ltd. | Sulfamethazine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-441 | Huvepharma EOOD | Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-443 | First Priority, Inc. | Sulfadimethoxine | Supplemental application approved to change to veterinary oversight* |
Generic | 200-455 | Cross Vetpharm Group Ltd. | Tylosin | Veterinary Oversight (79 FR 64114, October 28, 2014) |
Generic | 200-460 | Cross Vetpharm Group Ltd. | Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Generic | 200-473 | Huvepharma EOOD | Tylosin | Veterinary Oversight (79 FR 44277, July 31, 2014) |
Generic | 200-484 | Huvepharma EOOD | Tylosin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Generic | 200-494 | Cross Vetpharm Group Ltd. | Gentamicin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-510 | Pharmgate LLC | Chlortetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Generic | 200-531 | Huvepharma EOOD | Monensin, Tylosin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-532 | Huvepharma EOOD | Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-533 | Huvepharma EOOD | Monensin, Decoquinate, Tylosin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-534 | Huvepharma EOOD | Melengestrol, Tylosin, Monensin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-535 | Huvepharma EOOD | Lasalocid, Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-544 | Huvepharma EOOD | Tylosin, Zilpaterol, Melengestrol, Monensin | Supplemental application approved to change to veterinary oversight* |
Generic | 200-547 | Huvepharma EOOD | Monensin, Tylosin, Zilpaterol | Supplemental application approved to change to veterinary oversight* |
Combination | 012-548 | Elanco US, Inc. | Hygromycin B, Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Combination | 013-388 | Elanco US, Inc. | Hygromycin B, Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Combination | 036-361 | Zoetis Inc. | Amprolium, Sodium Sulfate, Chlortetracycline , Ethopabate | Supplemental application approved to change to veterinary oversight* |
Combination | 044-820 | Zoetis Inc. | Lincomycin, Amprolium, Ethopabate | Sponsor has requested withdrawal of approval* |
Combination | 044-972 | Zoetis Inc. | Lincomycin, Clopidol | Sponsor has requested withdrawal of approval* |
Combination | 045-444 | Zoetis Inc. | Chlortetracycline, Decoquinate | Supplemental application approved to change to veterinary oversight* |
Combination | 046-209 | Huvepharma EOOD | Chlortetracycline, Clopidol | Supplemental application approved to change to veterinary oversight* |
Combination | 046-718 | Zoetis Inc. | Melengestrol, Oxytetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Combination | 046-719 | Zoetis Inc | Melengestrol, Oxytetracycline | Supplemental application approved to remove production indication and change to veterinary oversight* |
Combination | 047-261 | Zoetis Inc. | Lincomycin, Decoquinate | Sponsor has requested withdrawal of approval* |
Combination | 047-262 | Zoetis Inc. | Lincomycin, Decoquinate | Sponsor has requested withdrawal of approval* |
Combination | 048-954 | Zoetis Inc. | Lincomycin, Zoalene | Sponsor has requested withdrawal of approval* |
Combination | 092-482 | Zoetis Inc. | Lincomycin, Monensin | Sponsor has requested withdrawal of approval* |
Combination | 092-507 | Zoetis Inc. | Robenidine, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 092-522 | Zoetis Inc. | Lincomycin, Monensin, Roxarsone | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 093-106 | Zoetis Inc. | Robenidine, Lincomycin | Sponsor has requested withdrawal of approval* |
Combination | 099-006 | Phibro Animal Health Corp. | Monensin, Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 101-666 | Phibro Animal Health Corp. | Robenidine, Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 101-689 | Zoetis Inc. | Lasalocid, Lincomycin | Sponsor has requested withdrawal of approval* |
Combination | 104-646 | Elanco US, Inc. | Monensin, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 107-997 | Phibro Animal Health Corp. | Lincomycin, Roxarsone, Nicarbazin | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 108-116 | Phibro Animal Health Corp. | Lincomycin, Nicarbazin | Sponsor has requested withdrawal of approval* |
Combination | 110-047 | Phibro Animal Health Corp. | Pyrantel, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 116-044 | Phibro Animal Health Corp. | Pyrantel, Lincomycin | Supplemental application approved to change to veterinary oversight* |
Combination | 120-724 | Phibro Animal Health Corp. | Monensin, Roxarsone, Virginiamycin | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 121-553 | Zoetis Inc. | Monensin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 122-481 | Phibro Animal Health Corp. | Monensin, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 122-608 | Phibro Animal Health Corp. | Lasalocid, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 122-822 | Phibro Animal Health Corp. | Amprolium, Virginiamycin, Ethopabate | Sponsor has requested withdrawal of approval* |
Combination | 137-537 | Zoetis Inc. | Lincomycin, Salinomycin | Sponsor has requested withdrawal of approval* |
Combination | 138-792 | Zoetis Inc. | Melengestrol, Monensin, Tylosin | Sponsor has requested withdrawal of approval* |
Combination | 138-828 | Phibro Animal Health Corp. | Salinomycin, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 138-870 | Zoetis Inc. | Melengestrol, Monensin, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 138-904 | Zoetis Inc. | Lasalocid, Melengestrol, Tylosin | Sponsor has requested withdrawal of approval* |
Combination | 138-941 | Zoetis Inc. | Pyrantel, Lincomycin | Supplemental application approved to change to veterinary oversight* |
Combination | 138-953 | Phibro Animal Health Corp. | Roxarsone, Salinomycin, Virginiamycin | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 138-992 | Zoetis Inc. | Lasalocid, Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 138-995 | Zoetis Inc. | Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 139-192 | Zoetis Inc. | Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 139-473 | Huvepharma EOOD | Halofuginone, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 140-340 | Huvepharma EOOD | Halofuginone, Lincomycin | Sponsor has requested withdrawal of approval* |
Combination | 140-448 | Phibro Animal Health Corp. | Salinomycin, Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 140-579 | Zoetis Inc. | Lasalocid, Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 140-859 | Zoetis Inc. | Salinomycin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 140-947 | Elanco US, Inc. | Lincomycin, Narasin, Nicarbazin | Sponsor has requested withdrawal of approval* |
Combination | 140-954 | Intervet, Inc. | Lincomycin, Fenbendazole | Supplemental application approved to remove production indication and change to veterinary oversight* |
Combination | 141-011 | Elanco US, Inc. | Chlortetracycline, Tiamulin | Supplemental application approved to change to veterinary oversight* |
Combination | 141-054 | Merial Ltd. | Ivermectin, Lincomycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Combination | 141-059 | Zoetis Inc. | Bacitracin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 141-090 | Huvepharma EOOD | Diclazuril, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 141-110 | Phibro Animal Health Corp. | Monensin, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 141-114 | Phibro Animal Health Corp. | Semduramicin, Virginiamycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Combination | 141-147 | Zoetis Inc. | Chlortetracycline, Decoquinate | Supplemental application approved to change to veterinary oversight* |
Combination | 141-149 | Zoetis Inc. | Monensin, Decoquinate, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 141-150 | Zoetis Inc. | Lasalocid, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 141-164 | Elanco US, Inc. | Monensin, Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Combination | 141-170 | Elanco US, Inc. | Narasin, Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Combination | 141-172 | Elanco US, Inc. | Ractopamine, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 141-185 | Zoetis Inc. | Chlortetracycline, Decoquinate | Supplemental application approved to change to veterinary oversight* |
Combination | 141-198 | Elanco US, Inc. | Salinomycin, Tylosin | Application Voluntarily Withdrawn (81 FR 59131, August 29, 2016; 81 FR 59135, August 29, 2016) |
Combination | 141-201 | Zoetis Inc. | Laidlomycin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 141-211 | Phibro Animal Health Corp. | Oxytetracycline, Carbadox | Supplemental application approved to change to veterinary oversight* |
Combination | 141-224 | Elanco US, Inc. | Monensin, Ractopamine, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 141-226 | Phibro Animal Health Corp. | Semduramicin, Roxarsone, Virginiamycin | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 141-233 | Elanco US, Inc. | Monensin, Ractopamine, Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 141-250 | Zoetis Inc. | Lasalocid, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 141-276 | Intervet, Inc. | Zilpaterol, Monensin, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 141-280 | Intervet, Inc. | Zilpaterol, Melengestrol, Monensin, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 141-289 | Phibro Animal Health Corp. | Semduramicin, Virginiamycin | Supplemental application approved to remove production indication and change to veterinary oversight* |
Combination | 141-430 | Phibro Animal Health Corp. | Virginiamycin, Monensin | Supplemental application approved to change to veterinary oversight* |
Combination | 200-090 | Huvepharma EOOD | Salinomycin, Lincomycin, Roxarsone | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 200-091 | Huvepharma EOOD | Salinomycin, Roxarsone, Chlortetracycline | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 200-092 | Huvepharma EOOD | Salinomycin, Virginiamycin | Sponsor has requested withdrawal of approval* |
Combination | 200-093 | Huvepharma EOOD | Salinomycin, Lincomycin | Sponsor has requested withdrawal of approval* |
Combination | 200-094 | Huvepharma EOOD | Salinomycin, Roxarsone, Virginiamycin | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 200-095 | Huvepharma EOOD | Salinomycin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-096 | Huvepharma EOOD | Salinomycin, Oxytetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-170 | Phibro Animal Health Corp. | Lincomycin, Roxarsone, Nicarbazin | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 200-171 | Phibro Animal Health Corp. | Lincomycin, Nicarbazin | Sponsor has requested withdrawal of approval* |
Combination | 200-242 | Zoetis Inc. | Bacitracin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-259 | Zoetis Inc. | Salinomycin, Roxarsone, Chlortetracycline | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 200-260 | Zoetis Inc. | Salinomycin, Roxarsone, Chlortetracycline | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 200-261 | Zoetis Inc. | Salinomycin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-262 | Zoetis Inc. | Salinomycin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-263 | Zoetis Inc. | Monensin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-354 | Pharmgate LLC | Monensin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-355 | Pennfield Oil Co. | Salinomycin, Roxarsone, Chlortetracycline | Application Voluntarily Withdrawn (79 FR 10974, February 27, 2014; 79 FR 10976, February 27, 2014) |
Combination | 200-356 | Pharmgate LLC | Chlortetracycline, Tiamulin | Supplemental application approved to change to veterinary oversight* |
Combination | 200-357 | Pharmgate LLC | Salinomycin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-358 | Pharmgate LLC | Bacitracin, Chlortetracycline | Supplemental application approved to change to veterinary oversight* |
Combination | 200-359 | Pharmgate LLC | Chlortetracycline, Decoquinate | Supplemental application approved to change to veterinary oversight* |
Combination | 200-375 | Elanco US, Inc. | Melengestrol, Monensin, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 200-424 | Elanco US, Inc. | Monensin, Ractopamine, Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 200-427 | Elanco US, Inc. | Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 200-430 | Elanco US, Inc. | Lasalocid, Melengestrol, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 200-480 | Elanco US, Inc. | Melengestrol, Tylosin, Monensin, Zilpaterol | Supplemental application approved to change to veterinary oversight* |
Combination | 200-530 | Huvepharma EOOD | Tylosin, Ractopamine | Supplemental application approved to change to veterinary oversight* |
Combination | 200-558 | Zoetis Inc. | Tylosin, Ractopamine | Supplemental application approved to change to veterinary oversight* |
Combination | 200-561 | Zoetis Inc. | Tylosin, Monensin, Ractopamine | Supplemental application approved to change to veterinary oversight* |
Combination | 200-562 | Zoetis Inc. | Tylosin, Monensin, Ractopamine, MGA | Supplemental application approved to change to veterinary oversight* |
Combination | 200-566 | Huvepharma EOOD | Tylosin, Monensin, Ractopamine | Supplemental application approved to change to veterinary oversight* |
Combination | 200-567 | Huvepharma EOOD | Tylosin, Monensin, Ractopamine, MGA | Supplemental application approved to change to veterinary oversight* |
Combination | 200-569 | Huvepharma EOOD | Tylosin, Salinomycin | Sponsor has requested withdrawal of approval* |
Combination | 200-570 | Huvepharma EOOD | Tylosin, Salinomycin | Sponsor has requested withdrawal of approval* |
Combination | 200-580 | Huvepharma EOOD | Tylosin, Salinomycin | Sponsor has requested withdrawal of approval* |
Combination | 200-583 | Zoetis Inc. | Ractopamine, Monensin, Tylosin, MGA | Supplemental application approved to change to veterinary oversight* |
Combination | 200-584 | Zoetis Inc. | Ractopamine, Tylosin | Supplemental application approved to change to veterinary oversight* |
Combination | 200-585 | Zoetis Inc. | Ractopamine, Monensin, Tylosin | Supplemental application approved to change to veterinary oversight* |
*FR Notice Pending